{"DataElement":{"publicId":"2646443","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Disease Marker Assessment Status","preferredDefinition":"the status of the disease marker malignant neoplasms (lesions) being followed during treatment.","longName":"KS_MN_DM_ASSESS_STAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2640032","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Disease Marker Assessment","preferredDefinition":"information relating to an assessment of disease marker (specific characteristics that may simplify the diagnostic process or help track disease progression) malignant neoplasms (lesions) in Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells).","longName":"KS_MALNEO_DM_ASSESS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2640017","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin however, it may also occur internally.  It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9087:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FA69F5-9B59-3F85-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-21","modifiedBy":"ONEDATA","dateModified":"2007-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2646340","version":"1","preferredName":"Disease Marker Assessment","preferredDefinition":"Specific molecular signature of disease, physiological measurement, genotype structural or functional characteristic, metabolic changes, or other determinant that may simplify the diagnostic process, make diagnoses more accurate, distinguish different causes of disease, or enable physicians to make diagnoses before symptoms appear and to track disease progression.:The final result of a determination of the value, significance, or extent of.","longName":"C18329:C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Marker","conceptCode":"C18329","definition":"Specific molecular signature of disease, physiological measurement, genotype structural or functional characteristic, metabolic changes, or other determinant that may simplify the diagnostic process, make diagnoses more accurate, distinguish different causes of disease, or enable physicians to make diagnoses before symptoms appear and to track disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31DC07A5-6C8B-029B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-01","modifiedBy":"ONEDATA","dateModified":"2007-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30F9EAD2-F896-4735-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-12-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2646444","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Disease Marker Assessment Status","preferredDefinition":"the status of the disease marker malignant neoplasms (lesions) being followed during treatment.","longName":"KS_MN_DM_ASSESS_STAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"120","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Complete resolution","valueDescription":"Complete resolution","ValueMeaning":{"publicId":"2646436","version":"1","preferredName":"Complete resolution","longName":"2646436","preferredDefinition":"Complete resolution","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EDE3A3-B4FC-0C65-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31EF4770-F796-0B3A-E044-0003BA3F9857","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"ONEDATA","dateModified":"2007-06-02","deletedIndicator":"No"},{"value":">=50% decrease in the sum of the products of the diameters of all marker lesions since baseline","valueDescription":">=50% decrease in the sum of the products of the diameters of all marker lesions since baseline","ValueMeaning":{"publicId":"2646445","version":"1","preferredName":">=50% decrease in the sum of the products of the diameters of all marker lesions since baseline","longName":"2646445","preferredDefinition":">=50% decrease in the sum of the products of the diameters of all marker lesions since baseline","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EF4341-17D5-0AB1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31EF4770-F7A7-0B3A-E044-0003BA3F9857","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"ONEDATA","dateModified":"2007-06-02","deletedIndicator":"No"},{"value":"None of the above","valueDescription":"None of the above","ValueMeaning":{"publicId":"2577583","version":"1","preferredName":"None of the above","longName":"2577583v1.00","preferredDefinition":"None of the choices above are suitable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None of the Above","conceptCode":"C133298","definition":"None of the choices above are suitable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FC1C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-02-07","modifiedBy":"KUMMEROA","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"31EF4770-F7C5-0B3A-E044-0003BA3F9857","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"ONEDATA","dateModified":"2007-06-02","deletedIndicator":"No"},{"value":">=25% inc in sum of the products of the diam of all marker lesions since baseline/best response","valueDescription":">=25% inc in sum of the products of the diam of all marker lesions since baseline/best response","ValueMeaning":{"publicId":"3119073","version":"1","preferredName":">=25% inc in sum of the products of the diam of all marker lesions since baseline/best response","longName":"3119073","preferredDefinition":">=25% inc in sum of the products of the diam of all marker lesions since baseline/best response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ACCEA49-48FE-80E9-E040-BB89AD4366BB","latestVersionIndicator":"Yes","beginDate":"2010-07-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-07-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ACCEA49-4917-80E9-E040-BB89AD4366BB","beginDate":"2010-07-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-07-07","modifiedBy":"ONEDATA","dateModified":"2010-07-07","deletedIndicator":"No"},{"value":"Less than 25% increase","valueDescription":"Less than 25% increase","ValueMeaning":{"publicId":"5839224","version":"1","preferredName":"Less than 25% increase","longName":"5839224","preferredDefinition":"Less than 25% increase","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50739837-B174-7089-E053-F662850A67ED","latestVersionIndicator":"Yes","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5073BC34-15FE-2DCA-E053-F662850A5F40","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"ONEDATA","dateModified":"2017-05-26","deletedIndicator":"No"},{"value":"Decrease greater than or equal to 50%","valueDescription":"Decrease greater than or equal to 50%","ValueMeaning":{"publicId":"5839225","version":"1","preferredName":"Decrease greater than or equal to 50%","longName":"5839225","preferredDefinition":"Decrease greater than or equal to 50%","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"50739837-B197-7089-E053-F662850A67ED","latestVersionIndicator":"Yes","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"507120EF-8A3A-03DD-E053-F662850AEE2A","beginDate":"2017-05-26","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-05-26","modifiedBy":"ONEDATA","dateModified":"2017-05-26","deletedIndicator":"No"},{"value":"<25% increase in the sum of the product of the diameters of all marker lesions compared to baseline or best response","valueDescription":"<25% increase in the sum of the product of the diameters of all marker lesions compared to baseline or best response","ValueMeaning":{"publicId":"7372075","version":"1","preferredName":"<25% increase in the sum of the product of the diameters of all marker lesions compared to baseline or best response","longName":"7372075","preferredDefinition":"<25% increase in the sum of the product of the diameters of all marker lesions compared to baseline or best response","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81E05F-3530-30E5-E053-4EBD850A6C5C","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81E05F-3549-30E5-E053-4EBD850A6C5C","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":">=25% increase in the sum of the product of the diameters of all marker lesions","valueDescription":">=25% increase in the sum of the product of the diameters of all marker lesions","ValueMeaning":{"publicId":"7372074","version":"1","preferredName":">=25% increase in the sum of the product of the diameters of all marker lesions","longName":"7372074","preferredDefinition":">=25% increase in the sum of the product of the diameters of all marker lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81E05F-350D-30E5-E053-4EBD850A6C5C","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81E05F-3526-30E5-E053-4EBD850A6C5C","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"<50% decrease in the sum of the product of the diameters of all marker lesions","valueDescription":"<50% decrease in the sum of the product of the diameters of all marker lesions","ValueMeaning":{"publicId":"7372076","version":"1","preferredName":"<50% decrease in the sum of the product of the diameters of all marker lesions","longName":"7372076","preferredDefinition":"<50% decrease in the sum of the product of the diameters of all marker lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81E05F-3553-30E5-E053-4EBD850A6C5C","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81E05F-356C-30E5-E053-4EBD850A6C5C","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":">=50% decrease in the sum of the product of the diameters of all marker lesions","valueDescription":">=50% decrease in the sum of the product of the diameters of all marker lesions","ValueMeaning":{"publicId":"7372077","version":"1","preferredName":">=50% decrease in the sum of the product of the diameters of all marker lesions","longName":"7372077","preferredDefinition":">=50% decrease in the sum of the product of the diameters of all marker lesions","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81E05F-3576-30E5-E053-4EBD850A6C5C","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81E05F-358F-30E5-E053-4EBD850A6C5C","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"},{"value":"Complete resolution of any detectable residual disease","valueDescription":"Complete resolution of any detectable residual disease","ValueMeaning":{"publicId":"7372078","version":"1","preferredName":"Complete resolution of any detectable residual disease","longName":"7372078","preferredDefinition":"Complete resolution of any detectable residual disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB81E05F-3599-30E5-E053-4EBD850A6C5C","latestVersionIndicator":"Yes","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB81E05F-35B2-30E5-E053-4EBD850A6C5C","beginDate":"2020-07-28","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-28","modifiedBy":"ONEDATA","dateModified":"2020-07-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EF0978-3DCA-0BF7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"CAMPBELB","dateModified":"2020-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7312662","version":"1","longName":"KS","context":"AMC"}]}],"AlternateNames":[{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"RESP_TRORRES","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Evaluation of Marker Lesions","type":"Preferred Question Text","description":"Evaluation of Marker Lesions","url":null,"context":"CTEP"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Marker lesion Area","url":null,"context":"Theradex"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31EF088A-3BAB-0CA5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-02","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-02","modifiedBy":"COLLIED","dateModified":"2020-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}